Development of a centralized, quality-controlled, quality-assured facility for the procurement, processing, storage, and distribution of normal and malignant tissue specimens and corresponding blood specimens [ Time Frame: 30 years ] [ Designated as safety issue: No ]

Support and enhance translational, clinical and basic research for Lineberger Comprehensive Cancer Center (LCCC) members (and non-members who have an LCCC member as sponsor and collaborator) with IRB-approved studies.

Maintain responsible and appropriate policies and procedures that ensure good patient care and responsible conduct of research.

Address medical and legal issues, and protect participant and patient privacy and confidentiality.

Provide a responsible and uniform mechanism for the integrated coordination of the hemato-pathologist and surgeon or hematology/oncology staff, researcher, and protocol office to obtain appropriate specimens for researchers.

Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following:

Acute myeloid leukemia

Acute lymphoblastic leukemia

Chronic myelogenous leukemia

Chronic lymphoid leukemia

Non-Hodgkin lymphoma

Hodgkin lymphoma

Myelodysplastic syndromes

Myeloproliferative disorders

Multiple myeloma

Waldenstrom macroglobulinemia

Aplastic anemia

Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage

Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital

PATIENT CHARACTERISTICS:

Not specified

PRIOR CONCURRENT THERAPY:

Not specified

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01137643

Locations

United States, North Carolina

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill